Considering that Mayo has been an integral asset through the entire submission process . They've had plenty of time to prepare for the IDE approval event
Just an observation, but noteworthy none the less, if you have been and you are longer term RDGL.....
The stock began it's undeterred MARCH Northward back in MARCH of this year. MARCH 1st the stock opened at 0.0524 and ended the month with a 0.07225 share price. Since then there has been no looking back. The stock has been stably trading at or near 4 year highs for a few months now all the while doing so at a more consistence base than years prior and with more shares out in the market than years prior (The last time RDGL traded anywhere NEAR OR ABOVE .20 cents was in January 2021 when it traded above .20 cents no more than 3 days, then fell back below .07 cents in a matter of a just a few) For those serious long term investors who have been accumulating shares a little along. Well I would have to reasonable assume that they are ecstatic with the current PPS and the way it's been trading along with the potential for bigger gains yet to be realized in the not so distant future upon FDA approval!
News 
Market Data 
Discover 
AI
